FDA Approves Alymsys® (bevacizumab-maly), a Biosimilar of Bevacizumab by Amneal Pharmaceuticals, Inc., developed by mAbxienceMiguel Martínez-Cava2022-04-19T22:57:54+02:00April 19, 2022|News|
Insud Pharma and Fresenius Kabi combine efforts to accelerate the growth of mAbxienceMiguel Martínez-Cava2022-05-25T23:46:17+02:00March 31, 2022|News|
Cipla enters partnership to provide affordable oncology biosimilars to South AfricaMiguel Martínez-Cava2022-03-30T15:32:26+02:00March 30, 2022|News|